Belite Bio (BLTE) Total Liabilities (2020 - 2026)

Belite Bio's Total Liabilities history runs 6 years deep, the most recent figure standing at $15.5 million for Q1 2026.

• In Q1 2026, Total Liabilities rose 152.54% year-over-year to $15.5 million; the TTM figure through Mar 2026 stood at $15.5 million (up 152.54% YoY), while the FY2025 annual figure was $10.1 million, up 59.56% from the prior year.
• Total Liabilities for Q1 2026 stood at $15.5 million, up from $10.1 million in the prior quarter.
• The five-year high for Total Liabilities was $15.5 million in Q1 2026, with the low at $2.8 million in Q4 2022.
• The 5-year median for Total Liabilities is $4.9 million (2023), against an average of $6.2 million.
• The sharpest annual moves came in 2024 and 2026: Total Liabilities decreased 24.63% in 2024, then jumped 152.54% in 2026.
• Belite Bio's Total Liabilities stood at $2.8 million in 2022, then surged by 51.91% to $4.2 million in 2023, then jumped by 49.87% to $6.3 million in 2024, then jumped by 59.56% to $10.1 million in 2025, then surged by 53.75% to $15.5 million in 2026.
• Business Quant data shows BLTE's Total Liabilities at $15.5 million in Q1 2026, $10.1 million in Q4 2025, and $8.3 million in Q3 2025.